Related Experiment Video
Updated: Jun 26, 2026

10:26
In Vitro Differentiation Model of Human Normal Memory B Cells to Long-lived Plasma Cells
Published on: January 20, 2019
Expression pattern of XBP1(S) in human B-cell lymphomas
Lorena Maestre1, Reuben Tooze, Marta Cañamero
1Monoclonal Antibodies Unit, Biotechnology Program, Spanish National Cancer Centre (CNIO), Madrid, Spain.
Haematologica
|January 30, 2009
Summary
The active form of X-box-binding protein 1 (XBP1(S)) marks advanced plasma cell differentiation. This study identifies XBP1(S) as a specific marker in lymphoid malignancies, aiding in assessing endoplasmic reticulum stress in human tumors.
Area of Science:
- Molecular Biology
- Immunology
- Oncology
Background:
- X-box-binding protein 1 (XBP1) is crucial for plasma cell differentiation and immunoglobulin production.
- XBP1 activity is regulated by mRNA splicing in response to endoplasmic reticulum (ER) stress, yielding the active XBP1(S) form.
- The expression of XBP1(S) in human tissues and its role in hematologic malignancies remain largely uncharacterized.
Purpose of the Study:
- To define the expression of XBP1(S) in normal and neoplastic lymphoid tissues using a novel antibody.
- To establish XBP1(S) as a specific marker for advanced plasma cell differentiation.
- To investigate the utility of XBP1(S) in characterizing lymphoid malignancies and assessing ER stress.
Main Methods:
- Development and application of a novel antibody for detecting XBP1(S).
- Analysis of XBP1(S) expression in a large cohort of normal and neoplastic lymphoid tissues.
- Correlation of XBP1(S) expression with plasma cell differentiation and specific hematologic malignancies.
Main Results:
- XBP1(S) expression was confirmed as a specific marker of advanced plasma cell differentiation.
- In lymphoid malignancies, XBP1(S) was predominantly found in plasma cell-derived neoplasms and plasmablastic diffuse large B-cell lymphomas.
- XBP1(S) expression revealed heterogeneity within plasmablastic diffuse large B-cell lymphomas, identifying a distinct subgroup.
- The study provides a practical method for assessing ER stress in human tumors.
Conclusions:
- XBP1(S) is a reliable marker for advanced plasma cell differentiation and specific lymphoid cancers.
- XBP1(S) aids in classifying plasmablastic diffuse large B-cell lymphomas and understanding tumor heterogeneity.
- Assessing XBP1(S) offers a direct approach to evaluating endoplasmic reticulum stress in human tumors.

